LXRX logo

Lexicon Pharmaceuticals (LXRX) Interest Expense

Annual Interest Expense

$13.10 M
+$10.32 M+371.26%

December 31, 2023

Summary

Performance

1-Year Change

+371.26%

3-Year Change

-9.92%

5-Year Change

-36.94%

15-Year Change

+87.59%

LXRX Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

70.29%
LXRX annual interest expense is higher than 70.29% of companies in Healthcare sector

High & Low

All-time High

$20.78 M
LXRX annual interest expense is currently -36.94% below its historical high of $20.78 million

3-Year Low

$802.00 K
LXRX annual interest expense is currently +1533.54% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
LXRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 2, 2025
LXRX next annual earnings announcement is scheduled for May 2, 2025

OtherLXRXexpensesmetrics:

Annual Total Expenses

$172.95 M
LXRX annual total expenses is $172.95 million

Annual Operating Expenses

$172.87 M
LXRX annual total operating expenses is $172.87 million

Annual Cost Of Goods Sold

$85.00 K
LXRX annual cost of goods sold is $85.00 thousand

Annual Income Tax

-
LXRX annual income tax value is unknown

Quarterly Interest Expense

$4.56 M
+$2.35 M+106.33%

September 30, 2024

Summary

Performance

3-Month Change

+106.33%

1-Year Change

-7.8%

3-Year Change

+428.01%

5-Year Change

-12.34%

LXRX Quarterly Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.58%
LXRX quarterly interest expense is higher than 69.58% of companies in Healthcare sector

High & Low

All-time High

$5.42 M
LXRX quarterly interest expense is currently -15.85% below its historical high of $5.42 million

3-Year Low

$110.00 K
LXRX quarterly interest expense is currently +4047.27% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LXRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 2, 2025
LXRX next earnings announcement is scheduled for May 2, 2025

OtherLXRXexpensesmetrics:

Quarterly Total Expenses

$65.44 M
LXRX quarterly total expenses is $65.44 million

Quarterly Operating Expenses

$65.37 M
LXRX quarterly total operating expenses is $65.37 million

Quarterly Cost Of Goods Sold

$71.00 K
LXRX quarterly cost of goods sold is $71.00 thousand

Quarterly Income Tax

-
LXRX quarterly income tax value is unknown

TTM Interest Expense

$17.14 M
+$663.00 K+4.02%

September 30, 2024

Summary

Performance

3-Month Change

+4.02%

1-Year Change

+5.63%

3-Year Change

+769.27%

5-Year Change

-17.09%

LXRX TTM Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

70%
LXRX TTM interest expense is higher than 70% of companies in Healthcare sector

High & Low

All-time High

$20.78 M
LXRX TTM interest expense is currently -17.51% below its historical high of $20.78 million

3-Year Low

$745.00 K
LXRX TTM interest expense is currently +2200.94% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LXRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 2, 2025
LXRX next earnings announcement is scheduled for May 2, 2025

OtherLXRXexpensesmetrics:

Annual Total Expenses

$172.95 M
LXRX annual total expenses is $172.95 million

Annual Operating Expenses

$172.87 M
LXRX annual total operating expenses is $172.87 million

TTM Cost Of Goods Sold

$338.00 K
LXRX TTM cost of goods sold is $338.00 thousand

TTM Income Tax

-
LXRX TTM income tax value is unknown

Interest Expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

LXRX Interest Expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+371.3%-7.8%+5.6%
3 y3 years-9.9%+428.0%+769.3%
5 y5 years-36.9%-12.3%-17.1%

LXRX Interest Expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+1533.5%-15.8%+4047.3%at high+2200.9%
5 y5-year-36.6%+1533.5%-15.8%+4047.3%-17.1%+2432.1%
alltimeall time-36.9%+1533.5%-15.8%+4047.3%-17.5%+2458.5%

Lexicon Pharmaceuticals Interest Expense History

DateAnnualQuarterlyTTM
Sep 2024
-
$4.56 M(+106.3%)
$17.14 M(+4.0%)
Jun 2024
-
$2.21 M(-55.3%)
$16.48 M(+1.5%)
Mar 2024
-
$4.95 M(-8.7%)
$16.23 M(+23.9%)
Dec 2023
$13.10 M(+371.3%)
$5.42 M(+39.0%)
$13.10 M(+49.2%)
Sep 2023
-
$3.90 M(+98.9%)
$8.78 M(+52.8%)
Jun 2023
-
$1.96 M(+7.6%)
$5.75 M(+28.0%)
Mar 2023
-
$1.82 M(+65.1%)
$4.49 M(+61.5%)
Dec 2022
$2.78 M(+246.6%)
$1.10 M(+27.7%)
$2.78 M(+41.0%)
Sep 2022
-
$864.00 K(+22.9%)
$1.97 M(+54.2%)
Jun 2022
-
$703.00 K(+539.1%)
$1.28 M(+71.7%)
Mar 2022
-
$110.00 K(-62.7%)
$745.00 K(-7.1%)
Dec 2021
$802.00 K(-94.5%)
$295.00 K(+72.5%)
$802.00 K(+18.5%)
Sep 2021
-
$171.00 K(+1.2%)
$677.00 K(-85.4%)
Jun 2021
-
$169.00 K(+1.2%)
$4.62 M(-51.7%)
Mar 2021
-
$167.00 K(-1.8%)
$9.58 M(-34.1%)
Dec 2020
$14.54 M(-29.7%)
$170.00 K(-95.9%)
$14.54 M(-25.7%)
Sep 2020
-
$4.12 M(-19.6%)
$19.57 M(-5.3%)
Jun 2020
-
$5.13 M(-0.1%)
$20.65 M(-0.2%)
Mar 2020
-
$5.13 M(-1.2%)
$20.69 M(+0.1%)
Dec 2019
$20.68 M(-0.5%)
$5.19 M(-0.2%)
$20.68 M(-0.2%)
Sep 2019
-
$5.20 M(+0.8%)
$20.71 M(-0.2%)
Jun 2019
-
$5.16 M(+0.9%)
$20.76 M(-0.1%)
Mar 2019
-
$5.12 M(-2.1%)
$20.78 M(+0.0%)
Dec 2018
$20.78 M(+197.5%)
$5.22 M(-0.5%)
$20.78 M(+17.3%)
Sep 2018
-
$5.25 M(+1.3%)
$17.71 M(+25.8%)
Jun 2018
-
$5.19 M(+1.4%)
$14.08 M(+34.0%)
Mar 2018
-
$5.11 M(+136.4%)
$10.51 M(+50.5%)
Dec 2017
$6.98 M(+6.3%)
$2.16 M(+33.6%)
$6.98 M(+8.2%)
Sep 2017
-
$1.62 M(+0.3%)
$6.46 M(-0.4%)
Jun 2017
-
$1.61 M(+1.6%)
$6.48 M(-0.4%)
Mar 2017
-
$1.59 M(-2.8%)
$6.51 M(-0.9%)
Dec 2016
$6.57 M
$1.63 M(-0.7%)
$6.57 M(-0.7%)
Sep 2016
-
$1.65 M(+0.5%)
$6.61 M(-0.6%)
DateAnnualQuarterlyTTM
Jun 2016
-
$1.64 M(-0.7%)
$6.65 M(-0.3%)
Mar 2016
-
$1.65 M(-1.7%)
$6.67 M(-0.8%)
Dec 2015
$6.72 M(+198.4%)
$1.68 M(-0.5%)
$6.72 M(+13.2%)
Sep 2015
-
$1.69 M(+1.9%)
$5.94 M(+26.4%)
Jun 2015
-
$1.66 M(-2.8%)
$4.70 M(+34.3%)
Mar 2015
-
$1.70 M(+90.8%)
$3.50 M(+55.3%)
Dec 2014
$2.25 M(+14.3%)
$892.00 K(+98.7%)
$2.25 M(+22.6%)
Sep 2014
-
$449.00 K(-1.3%)
$1.84 M(-2.3%)
Jun 2014
-
$455.00 K(-0.4%)
$1.88 M(-2.1%)
Mar 2014
-
$457.00 K(-4.2%)
$1.92 M(-2.5%)
Dec 2013
$1.97 M(-6.8%)
$477.00 K(-3.0%)
$1.97 M(-2.1%)
Sep 2013
-
$492.00 K(-0.8%)
$2.01 M(-1.7%)
Jun 2013
-
$496.00 K(-2.0%)
$2.05 M(-1.6%)
Mar 2013
-
$506.00 K(-2.7%)
$2.08 M(-1.5%)
Dec 2012
$2.11 M(-16.4%)
$520.00 K(-1.3%)
$2.11 M(-1.4%)
Sep 2012
-
$527.00 K(-0.6%)
$2.15 M(-1.5%)
Jun 2012
-
$530.00 K(-1.3%)
$2.18 M(-11.4%)
Mar 2012
-
$537.00 K(-2.5%)
$2.46 M(-2.8%)
Dec 2011
$2.53 M(-7.0%)
$551.00 K(-1.6%)
$2.53 M(-2.9%)
Sep 2011
-
$560.00 K(-30.9%)
$2.60 M(-2.9%)
Jun 2011
-
$810.00 K(+33.4%)
$2.68 M(+3.1%)
Mar 2011
-
$607.00 K(-3.0%)
$2.60 M(-4.4%)
Dec 2010
$2.72 M(-8.3%)
$626.00 K(-1.7%)
$2.72 M(-5.6%)
Sep 2010
-
$637.00 K(-12.6%)
$2.88 M(-4.9%)
Jun 2010
-
$729.00 K(+0.3%)
$3.03 M(0.0%)
Mar 2010
-
$727.00 K(-7.5%)
$3.03 M(+2.1%)
Dec 2009
$2.97 M(+10.2%)
$786.00 K(+0.1%)
$2.97 M(+36.1%)
Sep 2009
-
$785.00 K(+7.7%)
$2.18 M(+56.3%)
Jun 2009
-
$729.00 K(+9.5%)
$1.40 M(+4.0%)
Mar 2009
-
$666.00 K(-1.3%)
$1.34 M(-0.3%)
Dec 2008
$2.69 M
-
-
Jun 2008
-
$675.00 K(+0.7%)
$1.34 M(+100.7%)
Mar 2008
-
$670.00 K
$670.00 K

FAQ

  • What is Lexicon Pharmaceuticals annual interest expense?
  • What is the all time high annual interest expense for Lexicon Pharmaceuticals?
  • What is Lexicon Pharmaceuticals annual interest expense year-on-year change?
  • What is Lexicon Pharmaceuticals quarterly interest expense?
  • What is the all time high quarterly interest expense for Lexicon Pharmaceuticals?
  • What is Lexicon Pharmaceuticals quarterly interest expense year-on-year change?
  • What is Lexicon Pharmaceuticals TTM interest expense?
  • What is the all time high TTM interest expense for Lexicon Pharmaceuticals?
  • What is Lexicon Pharmaceuticals TTM interest expense year-on-year change?

What is Lexicon Pharmaceuticals annual interest expense?

The current annual interest expense of LXRX is $13.10 M

What is the all time high annual interest expense for Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals all-time high annual interest expense is $20.78 M

What is Lexicon Pharmaceuticals annual interest expense year-on-year change?

Over the past year, LXRX annual interest expense has changed by +$10.32 M (+371.26%)

What is Lexicon Pharmaceuticals quarterly interest expense?

The current quarterly interest expense of LXRX is $4.56 M

What is the all time high quarterly interest expense for Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals all-time high quarterly interest expense is $5.42 M

What is Lexicon Pharmaceuticals quarterly interest expense year-on-year change?

Over the past year, LXRX quarterly interest expense has changed by -$386.00 K (-7.80%)

What is Lexicon Pharmaceuticals TTM interest expense?

The current TTM interest expense of LXRX is $17.14 M

What is the all time high TTM interest expense for Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals all-time high TTM interest expense is $20.78 M

What is Lexicon Pharmaceuticals TTM interest expense year-on-year change?

Over the past year, LXRX TTM interest expense has changed by +$914.00 K (+5.63%)